# A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions

> **NCT00865943** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 26 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Citalopram HBr eq. 10 mg tablets, single dose
- **DRUG:** CELEXATM 10 mg tablets, single dose

## Key facts

- **NCT ID:** NCT00865943
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-07
- **Primary completion:** 2003-08
- **Final completion:** 2003-08
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2010-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00865943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00865943, "A Relative Bioavailability Study of Citalopram HBr 10 mg Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00865943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*